“EFFICACY AND RISKS PROFILES OF ‘GLP-1 RECEPTOR AGONISTS’ IN TYPE 2 DIABETES AND OBESITY: A SYSTEMATIC REVIEW OF BENEFITS AND RISKS”. Review Journal of Neurological & Medical Sciences Review, vol. 3, no. 5, Sept. 2025, pp. 300-24, https://doi.org/10.63075/fmkjkn28.